 |
|
| Blog results | Results 1 - 10 of about 20,473 for b cell lymphoma. (0.41 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | The Millsap Family Updates - http://millsapfamily.blogspot.com/ | |
| 18 hours ago by drgunasakaran1 Treatment of non-Hodgkin's B-cell lymphoma. Approved for marketing: 6/27/2003. Corixa Corporation. ibritumomab (trade name: Zevalin) For treatment of B-cell non-Hodgkin's lymphoma. Approved for marketing: 2/19/02. IDEC Pharmaceuticals ... Pharmainfo.net - http://www.pharmainfo.net/ [ More results from Pharmainfo.net ] |
| 30 Oct 2009 by Lu, Y., Prescott, J., Sullivan-Halley,... Multivariable-adjusted relative risks and 95% confidence intervals were estimated by fitting Cox proportional hazards models for all B-cell NHL combined and for the 3 most common subtypes: diffuse large B-cell lymphoma, ... American Journal of Epidemiology - current issue - http://aje.oxfordjournals.org/ [ More results from American Journal of Epidemiology - current issue ] |
| 23 Nov 2009 by admin Abnormal activity in our immune system causes the outbreak that leads to a form of tumor called Lymphoma. Lymphatic cells are classified into two types; B lymphocytes and T lymphocytes. b cell lymphoma prognosis the common cause of ... thebutterstick.com - http://www.thebutterstick.com/ |
| 29 Oct 2009 by Gundrum, Mathiason, Moore, Go Primary Testicular Diffuse Large B-Cell Lymphoma: A Population-Based Study on the Incidence, Natural History, and Survival Comparison With Primary Nodal Counterpart Before and After the Introduction of Rituximab ... Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/ [ More results from Journal of Clinical Oncology Current Issue ] |
| 24 Nov 2009 by admin One type of non-hodgkins lymphoma is called diffuse large b cell lymphoma . This type of cancer progresses faster than the usual, or it can also originate from a slower lymphoma subtype. However; diffuse large B cell lymphoma should be ... idblogthat.net - http://www.idblogthat.net/ - References |
| 22 Nov 2009 by Russell Ryan, M.D. 75 y/o female with cervical lymphadenopathy. Virtual Slidebox - http://slidebox.path.mgh.harvard.edu/ |
| 24 Nov 2009 by Haioun, C., Mounier, N., Emile, JF, Ranta,... Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma. C. Haioun1,*, N. Mounier2, J. F. Emile3, D. Ranta4, ... Annals of Oncology - recent issues - http://annonc.oxfordjournals.org/ [ More results from Annals of Oncology - recent issues ] |
| 20 Nov 2009 Researchers are exploring ways to manipulate rituximab (Rituxan) when added to the current standard therapy for diffuse large B-cell lymphoma, specifically shortening the number of treatment days. Preliminary results of a phase III ... Cancer Network - http://www.cancernetwork.com/ [ More results from Cancer Network ] |
| 2 Dec 2008 by kernixc MZLs are a diverse group of lymphomas that can be divided into: lymphomas of mucosa-associated lymphoid tissue (MALT); splenic MZL; and nodal MZL. MabThera RSS News - http://www.mabthera.com/portal/eipf/pb/mabthera/mabthera [ More results from MabThera RSS News ] |
| 24 Oct 2009 by catias A recent study having as leading investigator doctor Michael Teitell from the University of California, Los Angeles discovered that the deregulations in the. Latest Cancer News - http://www.topcancernews.com/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
